4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001493152-21-016123
Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Humphrey David Carl Chief Financial Officer | 2021-06-30 | Grant or award | +50,000 | 50,000 | D |
Loading xslF345X03/ownership.xml…